Home Home Home Inbox Home Search

Event

Aerosol Furosemide (80 mg) for the Treatment of Exercise-Induced Dyspnea [Board No. P1440]

Location: Board no. P1440
Session Type: Thematic Poster Session
Tuesday
May
22
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Robert B. Banzett

PhD
Beth Israel Deaconess Med Ctr;Beth Israel Deaconess Medical Center and Harvard Medical School

Richard M. Schwartzstein

MD
Beth Israel Deaconess Medical Center and Harvard Medical School;Beth Israel Deaconess Medical Ctr

Andrew R. Sheridan

BA
Beth Israel Deaconess Medical Center

Robert W. Lansing

PhD
Beth Israel Deaconess Medical Center

Carl O'Donnell

DSc
Beth Israel Deaconess Medical Center;Beth Israel Deaconess Medical Center and Harvard Medical School

Robert Hallowell

MD
Beth Israel Deaconess Medical Center and Harvard Medical School;Beth Israel Deaconess Medical Ctr

View Abstract

Aerosol Furosemide (80 mg) for the Treatment of Exercise-Induced Dyspnea

Parent Sessions

  • C44 - CLINICAL ISSUES IN COPD II
    05-22-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search